You just read:

EB Pharma Announces License Agreement for Investigational Drug, Tipifarnib from Janssen Pharmaceutica for Development in Hepatitis Delta Virus (HDV) Infection

News provided by

Eiger Bio, Inc.

23 Dec, 2014, 12:00 GMT